Consultation outcome

Proposal to simplify the information requirements for advertising of medicinal products to prescribers and suppliers of medicines (MLX384)

From:
Medicines and Healthcare products Regulatory Agency
Published
24 February 2014
Last updated
1 October 2014 — See all updates
This consultation has concluded

Download the full outcome

Summary of responses to consultation: simplify the information requirements for advertising of medicinal products to prescribers and suppliers of medicines

Ref: MLX 384

PDF, 105 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail of outcome

Following a public consultation on proposals for amendments to medicines legislation to simplify the information required to be included in some advertisements to prescribers and suppliers of medicines, the MHRA has decided that with effect from 1 October 2014 it will use the marketing authorisation and self-regulation to require that the short form of advertisement is not used for innovative medicines for the first two years after launch to ensure pharmacy staff have the opportunity to gain familiarity with the product. The MHRA has also gained agreement from PAGB to include a requirement that their Code of Practice will require that training materials always carry the full prescribing information.

Original consultation

Summary

MHRA is asking for feedback on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.

This consultation ran from
to

Consultation description

This consultation seeks views on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.

This would be achieved by amending the Human Medicines Regulations 2012 to extend the use of an existing abbreviated advertisement format.

No changes are proposed to the requirements for advertising to the public.

Comments should be sent to MHRA by 22 April 2014. Comments received after that date will not be considered.

Documents

Proposal to simplify the information requirements for advertising of medicinal products to prescribers and suppliers of medicines (MLX384)

Unnumbered command paper

PDF, 136 KB, 13 pages

Order a copy

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Published 24 February 2014
Last updated 1 October 2014 + show all updates

  1. Final outcome added.

  2. A response form has been added.

  3. First published.

Related content